Screening and Risk Factor Associated with Vulvovaginal Candidiasis among Pregnant Women

Abstract

Background: Vulvovaginal candidiasis is also known as vaginal yeast infection and candida vulvovaginitis there is excessive growth of yeast in vagina which leads to vaginal thrush. The sign and symptoms of vulvovaginal candidiasis includes severe vaginal discharge and itching. The symptoms get more before menstruation. The other symptoms show pain during sex, burning urination and redness over vagina. This infection mostly occurs due to excessive amount of growth of candida. According to research in all around 75% of total women suffer from vaginal candidiasis once in their lifetime and around 5% of the women suffer from twice or thrice. The preventive measures include wearing cotton undergarment rather than wearing synthetic and wearing loose cotton cloths.
 Objective: This study is planned to assess screening and risk factors associated with vulvovaginal candidiasis among pregnant women.
 Methodology: The Descriptive Evaluatory Research Design used for data collection procedure will be required 1 week per plan. 7-8 High vaginal swab are taken from gynae Opd in a day accordingly data will be collected. The number of pregnant women will be taken from Gynae Opd who come for check-up on the regular basis. Soon after their check-up written consent form will be given and sample will be collected. Then interview will be taken with the following questionnaires prepared according to the risk factors assessment scale. The pregnant women will be selected non-Probability convenient sampling technique.
 Conclusion: Reproductive age group women have more risk of developing vulvovaginal candidiasis, because of High oestrogen levels cause an increased glycogen load in epithelium, which is a nutritional source for growth of candida & germination. Vulvovaginal candidiasis the most common gynaecologic diagnosis in the primary care setting. So, the available statistics say that there is a need for the study regarding the assessment and screening of vulvovaginal candidiasis among pregnant women.